1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | |
| brand | String | Emgality |
| structure | File | |
| classes | List of String, delimiter: , | Anti-CGRP ligand monoclonal antibody |
| mechanism | String | Humanized IgG4 monoclonal antibody binding CGRP peptide; prevents CGRP from activating its receptor |
| uses | String | Preventive treatment of migraine in adults; episodic cluster headache |
| starting_dose | String | Migraine: 240 mg SC loading dose, then 120 mg SC monthly. Cluster: 300 mg SC at onset of cluster period, then monthly during cluster. |
| preparations | String | 120 mg/mL prefilled syringe or autoinjector |
| fda_max | String | 240 mg loading + 120 mg/month for migraine; 300 mg/month for cluster |
| pill_id | Text | |
| routes | List of String, delimiter: , | Subcutaneous |
| onset | String | Over weeks |
| duration | String | Monthly dosing |
| halflife | String | ~27 days |
| bioavailability | String | Not formally established (high SC) |
| pregnancy | String | Limited data; avoid |
| legal | String | Rx |
